These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11060438)

  • 1. Report of the third international workshop on human chromosome 10 mapping and sequencing 1999.
    Deloukas P; French L; Meitinger T; Moschonas NK
    Cytogenet Cell Genet; 2000; 90(1-2):1-12. PubMed ID: 11060438
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of the fifth international workshop on human chromosome 1 mapping 1999.
    White PS; Forus A; Matise TC; Schutte BC; Spieker N; Stanier P; Vance JM; Gregory SG
    Cytogenet Cell Genet; 1999; 87(3-4):143-71. PubMed ID: 10702659
    [No Abstract]   [Full Text] [Related]  

  • 3. Report and abstracts of the sixth international workshop on human chromosome 1 mapping 2000. Iowa City, Iowa, USA. 30 September-3 October 2000.
    Schutte BC; Carpten JD; Forus A; Gregory SG; Horii A; White PS
    Cytogenet Cell Genet; 2001; 92(1-2):23-41. PubMed ID: 11306795
    [No Abstract]   [Full Text] [Related]  

  • 4. Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus deletion interval.
    Peiffer-Schneider S; Noonan FC; Mutch DG; Simpkins SB; Herzog T; Rader J; Elbendary A; Gersell DJ; Call K; Goodfellow PJ
    Genomics; 1998 Aug; 52(1):9-16. PubMed ID: 9740666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele losses and onco-suppressor genes.
    Dunlop MG
    J Pathol; 1991 Jan; 163(1):1-5. PubMed ID: 2002418
    [No Abstract]   [Full Text] [Related]  

  • 6. [Genetics and cancer].
    Carnevale A; Salamanca-Gómez F; Lisker R; Orozco Orozco L
    Gac Med Mex; 1992; 128(2):107-25. PubMed ID: 1302207
    [No Abstract]   [Full Text] [Related]  

  • 7. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletions define a region of 8p23.2 containing a putative tumor suppressor gene.
    Sun PC; Schmidt AP; Pashia ME; Sunwoo JB; Scholnick SB
    Genomics; 1999 Dec; 62(2):184-8. PubMed ID: 10610711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assignment of BUB3 to human chromosome band 10q26 by in situ hybridization.
    Kwon TK; Hawkins AL; Griffin CA; Gabrielson E
    Cytogenet Cell Genet; 2000; 88(3-4):202-3. PubMed ID: 10828586
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncogenes and tumor suppressor genes: genetic changes mark the adenoma-carcinoma sequence].
    Schmiegel WH
    Internist (Berl); 1991 Jun; 32(6):315-20. PubMed ID: 1652573
    [No Abstract]   [Full Text] [Related]  

  • 13. Report of the third international workshop on human chromosome 22 mapping.
    Emanuel BS; Buetow K; Nussbaum R; Scambler P; Lipinski M; Overton GC
    Cytogenet Cell Genet; 1993; 63(4):206-11. PubMed ID: 8099004
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
    Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
    Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of microchromosomal aberrations in refractory epilepsy: a pilot study.
    McMahon JM; Scheffer IE; Nicholl JK; Waters W; Eyre H; Hinton L; Nelson P; Yu S; Dibbens LM; Berkovic SF; Mulley JC
    Epileptic Disord; 2010 Sep; 12(3):192-8. PubMed ID: 20643615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple genetic abnormalities of 11p15 in Wilms' tumor.
    Feinberg AP
    Med Pediatr Oncol; 1996 Nov; 27(5):484-9. PubMed ID: 8827078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Towards an allotype of second generation colon cancer].
    Buecher B; Schmitz A; Lerebours F; Thuille B; Thomas G; Olschwang S
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1004-10. PubMed ID: 8729412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
    Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D
    Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the second international workshop on human chromosome 10 mapping 1997.
    Meitinger T; Scharfe C; Call K; Moschonas N
    Cytogenet Cell Genet; 1997; 78(3-4):184-94. PubMed ID: 9465886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.